癌细胞挥发性有机化合物的综述:它们的新陈代谢和演变
Takeshi Furuhashi1, Kanako Toda2, Wolfram Weckwerth3,4,5
1NUS Environmental Research Institute, National University of Singapore, Singapore, Singapore.
Frontiers in molecular biosciences
|January 22, 2025
概括
使用挥发性有机化合物 (VOC) 的癌症查是有希望的. 需要进一步的研究来将癌症的特征与特定的VOC联系起来,以临床应用,重点关注代谢途径和活性氧物种 (ROS).
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
背景情况:
- 癌症是全球过早死亡的主要原因之一.
- 挥发性有机化合物 (VOC) 是用于非侵入性癌症查的新兴生物标志物.
- 了解癌症生物学与VOC产生之间的联系对于临床翻译至关重要.
研究的目的:
- 审查和比较细胞代谢,信号转导和线粒体代谢物转移与癌症进化有关的情况.
- 探索癌症特异性VOC生产的生物基础.
- 确定代谢交叉和VOC调节的未来研究领域.
主要方法:
- 文献审查和细胞过程的比较分析.
- 讨论癌症特征及其与VOC生成的联系.
- 检查ROS代谢的进化起源.
主要成果:
- 癌症的特征和ROS代谢与非癌症的增殖细胞有共同的起源.
- 细胞代谢,信号转导和线粒体功能是VOC生产的关键.
- 该审查强调了癌症特异性VOC来源的复杂性.
结论:
- 对代谢交叉和调节途径的进一步研究对于推进基于VOC的癌症诊断至关重要.
- 某些癌症特征和ROS系统的共同起源需要对VOC生物标志物的仔细解释.
- 弥合癌症生物学和VOC生产之间的差距是未来临床应用的关键.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K


